1540
N. Luo et al. / Tetrahedron: Asymmetry 22 (2011) 1536–1541
4.3.5. (S)-tert-Butyl (2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)
(4-fluorophenyl) methylcarbamate 7e
J = 8.8 Hz, 1H), 4.58 (s, 2H), 4.48 (q, J = 7.2 Hz, 2H), 1.46–1.42 (m,
12H); 13C NMR (100 MHz, CDCl3) d: 194.7, 180.0, 155.1, 146.4,
126.7, 124.3, 124.0, 94.6, 79.6, 74.9, 66.8, 28.4, 14.7; IR (thin film)
/cmꢀ1: 2978 (m), 2928 (w), 1726 (m), 1581 (m), 1482 (w), 1387 (s),
1012 (m), 763(m), 697(w); HRMS (ESI) calcd for C16H21NNaO5S
(M+Na)+: 362.1033, found: 362.1032; The enantiomeric excess
was determined by HPLC with a Chiralpak AS–H column (hex-
ane/2-PrOH = 90/10, k = 254 nm, 1.0 mL/min); tmajor = 23.06 min,
tminor = 42.31 min, 86% ee.
Light yellow oil,
½
a 2D0
ꢂ
¼ þ58:0 (c 0.10, CH2Cl2); 1H NMR
(400 MHz, CDCl3) d: 7.38–7.35 (m, 2H), 6.99–6.94 (m, 2H), 6.52
(d, J = 8.0 Hz, 1H), 5.51 (d, J = 8.4 Hz, 1H), 4.57 (d, J = 16.4 Hz, 1H),
4.52 (d, J = 16.0 Hz, 1H), 4.46 (qd, J = 7.2, 1.2 Hz, 2H), 1.45–1.41
(m, 12H); 13C NMR (100 MHz, CDCl3) d: 194.8, 180.1, 163.1,
160.7, 155.2, 138.7, 127.9, 127.8, 115.3, 115.1, 94.8, 79.5, 74.8,
66.7, 47.9, 28.4, 14.7; IR (thin film) m
/cmꢀ1: 2979 (m), 2928 (w),
1719 (m), 1618 (m), 1498 (w), 1388 (s), 1054 (m), 838 (w),
700(m); HRMS (ESI) calcd for C18H22FNNaO5 (M+Na)+: 374.1374,
found: .374.1377; The enantiomeric excess was determined by
HPLC with a Chiralpak AS–H column (hexane/2-PrOH = 90/10,
k = 254 nm, 1.0 mL/min); tmajor = 20.56 min, tminor = 18.47 min,
81% ee.
4.3.10. (R)-tert-Butyl (2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)
(furan-2-yl) methylcarbamate 7j
Light yellow oil,
½
a 2D0
ꢂ
¼ þ15:0 (c 0.22, CH2Cl2); 1H NMR
(400 MHz, CDCl3) d: 7.31 (br, 1H), 6.28–6.26 (m, 1H), 6.18 (br,
2H), 5.65 (d, J = 9.2 Hz, 1H), 4.58 (s, 2H), 4.48 (q, J = 7.2 Hz, 2H),
1.45–1.42 (m, 12H); 13C NMR (100 MHz, CDCl3) d: 194.8, 180.4,
155.1, 153.9, 141.8, 110.2, 105.7, 92.5, 79.6, 74.9, 66.7, 42.3, 28.4,
4.3.6. (S)-tert-Butyl (2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)
(2-methoxyphenyl) methylcarbamate 7f
14.7; IR (thin film) m
/cmꢀ1: 2979 (m), 2928 (w), 1727 (m), 1688
White solid, mp 123–124 °C; ½a D20
ꢂ
¼ þ27:5 (c 0.4, CH2Cl2); 1H
(m), 1482 (w), 1389 (s), 1007 (m), 788(m), 734(w); HRMS (ESI)
calcd for C16H21NNaO6 (M+Na)+: 364.1261, found: 364.1267; The
enantiomeric excess was determined by HPLC with a Chiralpak
AS–H column (hexane/2-PrOH = 90/10, k = 254 nm, 1.0 mL/min);
tmajor = 23.39 min, tminor = 33.22 min, 60% ee.
NMR (400 MHz, CDCl3) d: 7.48 (dd, J = 7.6, 1.6 Hz, 1H), 7.20 (td,
J = 8.0, 1.6 Hz, 1H), 6.91 (t, J = 6.4 Hz, 1H), 6.82 (d, J = 8.0 Hz, 1H,),
6.32 (d, J = 9.2 Hz, 1H), 5.88 (d, J = 8.8 Hz, 1H), 4.52–4.40 (m, 4H),
3.82 (s, 3H), 1.45–1.40 (m, 12H); 13C NMR (100 MHz, CDCl3) d:
195.0, 180.1, 156.4, 155.1, 130.1, 128.1, 127.7, 120.4, 110.6, 94.5,
79.1, 74.5, 66.1, 60.3, 55.3, 28.4, 14.7; IR (thin film)
m
/cmꢀ1: 2921
4.3.11. (S)-tert-Butyl cyclohexyl (2-ethoxy-4-oxo-4,5-dihydro-
(m), 2851 (w), 1718 (m), 1591 (m), 1492 (w), 1385 (s), 1051 (m),
752(w), 700(m); HRMS (ESI) calcd for C19H25NNaO6 (M+Na)+:
386.1574, found: 386.1573; The enantiomeric excess was deter-
furan-3-yl) methylcarbamate 7k
Light yellow oil,
½
a 2D0
ꢂ
¼ ꢀ19:2 (c 0.20, CH2Cl2); 1H NMR
(400 MHz, CDCl3) d: 5.89 (d, J = 9.6 Hz, 1H), 4.53–4.42 (m, 4H),
4.22 (t, J = 8.0 Hz, 1H), 1.79–1.60 (m, 6H), 1.44–1.41 (m, 12H),
1.21–1.11 (m, 3H), 0.99–0.86 (m, 2H); 13C NMR (100 MHz, CDCl3)
d: 195.8, 180.8, 155.6, 93.6, 78.8, 74.6, 66.2, 49.6, 43.0, 29.3, 28.4,
26.3, 26.0, 25.9, 14.7; IR (thin film) /cmꢀ1: 2979 (w), 2933 (m),
2922 (w) 1725 (m), 1688 (m), 1451 (w), 1388 (s), 1011 (m), 779
(w); HRMS (ESI) calcd for C18H28NNaO5 (M+Na)+: 362.1938, found:
362.1937; The enantiomeric excess was determined by HPLC with
a Chiralpak AS-H column (hexane/2-PrOH = 90/10, k = 254 nm,
1.0 mL/min); tmajor = 11.16 min, tminor = 16.66 min, 68% ee.
mined by HPLC with
a Chiralpak AS–H column (hexane/
2-PrOH = 90/10, k = 254 nm, 1.0 mL/min); tmajor = 12.18 min, tminor
=
15.88 min, 83% ee.
4.3.7. (S)-tert-Butyl (2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)
(4-methoxyphenyl) methylcarbamate 7g
Light yellow oil,
½
a 2D0
ꢂ
¼ þ34:9 (c 0.32, CH2Cl2); 1H NMR
(400 MHz, CDCl3) d: 7.33 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.8 Hz,
2H), 6.49 (d, J = 8.4 Hz, 1H), 5. 49 (d, J = 9.2 Hz, 1H), 4.56 (d,
J = 16.0 Hz, 1H), 4.51 (d, J = 16.0 Hz, 1H), 4.45(qd, J = 7.2, 1.4 Hz,
2H), 3.77 (s, 3H), 1.45–1.41 (m, 12H); 13C NMR (100 MHz, CDCl3)
d: 195.0, 180.1, 158.7, 155.2, 135.1, 127.5, 113.8, 95.1, 79.3, 74.8,
4.4. Preparation of (S)-tert-butyl (2-(butylamino)-4-oxo-4,5-
dihydrofuran-3-yl) (phenyl)methylcarbamate 8
66.6, 55.3, 47.9, 28.4, 14.7; IR (thin film) m
/cmꢀ1: 2978 (m), 2932
(w), 1720 (m), 1617 (m), 1441 (w), 1388 (s), 1013 (m), 860(m);
HRMS (ESI) calcd for C19H25NNaO6 (M+Na)+: 386.1574, found:
386.1572; The enantiomeric excess was determined by HPLC with
a Chiralpak AS–H column (hexane/2-PrOH = 90/10, k = 254 nm,
1.0 mL/min); tmajor = 23.87 min, tminor = 26.18 min, 63% ee.
A solution of 4a (33 mg, 0.1 mmol) and butylamine (0.4 mmol)
in methanol (3 mL) was stirred at 40 °C for 8 h. The solvent was
evaporated under vacuum, and the residue was purified by flash
column chromatography over silica gel (petroleum ether/ethyl ace-
tate = 2/1) to give 8 as a white solid, mp 137–138 °C; ½a D20
¼ þ24:1
ꢂ
(c 0.60, CH2Cl2); 1H NMR (400 MHz, CDCl3) d: 7.30 (br, 2H), 7.22–
7.18 (m, 2H), 7.14–7.11 (m, 1H), 6.67 (s, 1H), 5.47 (d, J = 8.0 Hz,
1H), 4.41 (d, J = 15.2 Hz, 1H), 4.36 (d, J = 15.2 Hz, 1H), 3.16 (br,
2H), 2.13 (s, 1H), 1.33 (s, 9H), 0.81–0.76 (t, J = 7.2 Hz, 3H), 1.19–
1.11 (m, 4H); 13C NMR (100 MHz, CDCl3) d: 191.8, 176.9, 156.4,
141.1, 128.4, 126.9, 126.4, 92.7, 79.5, 74.0, 48.2, 41.1, 31.8, 28.4,
19.7, 13.5; IR (KBr): 3553 (m), 2980 (w), 2873 (m), 1710 (m),
1689 (m), 1671 (m), 1429 (w), 1329 (m), 1076 (m), 811 (w), 752
4.3.8. (S)-tert-Butyl (2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)
(4-(trifluoromethyl)phenyl) methylcarbamate 7h
Light yellow oil,
½
a 2D0
ꢂ
¼ þ3:8 (c 0.34, CH2Cl2); 1H NMR
(400 MHz, CDCl3) d: 7.56–7.50 (m, 4H), 6.61 (d, J = 8.4 Hz, 1H),
5.57 (d, J = 8.4 Hz, 1H), 4.61–4.45 (m, 4H), 1.44 (t, J = 6.8 Hz, 3H),
1.42 (s, 9H); 13C NMR (100 MHz, CDCl3) d: 194.7, 180.2, 155.2,
146.7, 129.5, 129.1, 126.5, 125.5, 125.4, 122.8, 94.1, 79.7, 74.9,
66.9, 48.2, 28.4, 14.7; IR (thin film)
1725 (m), 1618 (m), 1484 (w), 1388 (s), 1016 (m), 798(m); HRMS
(ESI) calcd for
19H22F3NNaO5 (M+Na)+: 424.1342, found:
m
/cmꢀ1: 2980 (m), 2930 (w),
(m), 719 (m); HRMS (ESI) calcd for
359.1971, found: 359.1961; The enantiomeric excess was deter-
C
20H27N2O4 (MꢀH)ꢀ:
C
mined by HPLC with a Chiralpak AS–H column (hexane/2-
424.1346; The enantiomeric excess was determined by HPLC with
a Chiralpak AS–H column (hexane/2-PrOH = 90/10, k = 254 nm,
1.0 mL/min); tmajor = 12.86 min, tminor = 9.15 min, 76% ee.
PrOH = 90/10, k = 254 nm, 1.0 mL/min); tmajor = 8.59 min, tminor =
10.93 min, 87% ee.
Acknowledgments
4.3.9. (R)-tert-Butyl (2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)
(thiophen-2-yl) methylcarbamate 7i
Financial support from the National Natural Science Foundation
of China (Nos. 20772160, 20972195), Ministry of Health of China
(No. 2009ZX09501-017), and Fundamental Research Funds for
the Central Universities are gratefully acknowledged.
Light yellow oil,
(400 MHz, CDCl3) d: 7.14 (dd, J = 5.2, 1.2 Hz, 1H), 6.96 (d,
½
a 2D0
ꢂ
¼ þ19:2 (c 0.18, CH2Cl2); 1H NMR
J = 3.2 Hz, 1H), 6.91–6.88 (m, 1H), 6.42 (d, J = 8.8 Hz, 1H), 5.82 (d,